Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
39.36
+0.55 (1.42%)
Sep 21, 2026, 11:13 AM EDT - Market open
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $5.29 billion as of September 21, 2026. Its market cap has increased by 668.89% in one year.
Market Cap
5.29B
Enterprise Value
4.24B
1-Year Change
668.89%
Ranking
Category
Stock Price
$39.36
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $5.29B, an increase of 788.31%. That is a compound annual growth rate of 39.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 5.29B | 300.95% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 5.68B |
| Ligand Pharmaceuticals | 5.65B |
| CRISPR Therapeutics AG | 5.47B |
| Cogent Biosciences | 5.47B |
| PTC Therapeutics | 5.46B |
| Dianthus Therapeutics | 5.42B |
| Erasca | 5.17B |
| Parabilis Medicines | 5.16B |